ViroPharma Incorporated Said to Hire Goldman, Sachs & Co. Amid Sanofi (France), Shire plc Interest

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ViroPharma Inc. (VPHM), a producer of drugs that treat rare diseases, has attracted interest from suitors including European drugmakers Sanofi (SAN) and Shire Plc (SHP), said people with knowledge of the process. ViroPharma’s shares surged. ViroPharma began working with Goldman Sachs Group Inc. on a possible auction after fielding an unsolicited approach, said the people, who asked not to be named because talks are private. Goldman Sachs has actively sought other suitors for the Exton, Pennsylvania-based drugmaker since then, said one person. ViroPharma’s market value was about $2 billion before Bloomberg’s report.

Help employers find you! Check out all the jobs and post your resume.

Back to news